Sagimet Biosciences Inc. Series A
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMT and other ETFs, options, and stocks.About SGMT
Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).
SGMT Key Statistics
Stock Snapshot
With a market cap of 665.1M, Sagimet Biosciences Inc. Series A(SGMT) trades at $10.64. The stock has a price-to-earnings ratio of -8.36.
On 2026-09-08, Sagimet Biosciences Inc. Series A(SGMT) stock moved within a range of $10.64 to $11.17. With shares now at $10.64, the stock is trading 0.0% above its intraday low and -4.7% below the session's peak.
Trading volume for Sagimet Biosciences Inc. Series A(SGMT) stock has reached 805.36K, versus its average volume of 987.59K.
The stock's 52-week range extends from a low of $4.50 to a high of $11.24.
The stock's 52-week range extends from a low of $4.50 to a high of $11.24.
Analyst ratings
100%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.